We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 1, 2010

TEVA NEUROSCIENCE, INC. et al v. WATSON PHARMA, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 16, 2013

    Teva Wins Ban On Mylan Parkinson's Generic

    A New Jersey federal judge on Friday barred  Mylan Inc. from manufacturing, importing or selling its own version of Teva Pharmaceutical Industries Ltd.'s brand-name treatment for Parkinson's disease, Azilect, for more than three years, after the generic-drug maker stipulated its proposed generic infringed a Teva patent.

6 other articles on this case. View all »

Parties

To view the parties, register now.